STOCKS TELEGRAPH

Author: ST Staff

Marinus Pharmaceuticals (NASDAQ: MRNS) Is Popping Today. Here’s Why

Shares of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) traded up 51.66% after announcing the encouraging result of a Phase 3 trial evaluating its drug candidate ganaxolone in children and young adults with CDKL5 deficiency disorder (CDD), a rare type of epilepsy.

After the promising result of ganaxolone, Marinus has decided to submit the New Drug Application (NDA) to the US FDA in mid-2021. Not only this, but the company has also decided to submit Marketing Authorization Application (MAA) for ganaxolone for the treatment of CDD to the European Medicines Agency (EMA) by the end of Q3 2021.

Marinus Pharmaceutical has earlier participated in Morgan Stanley Virtual Global Healthcare Conference on September 15. The biotechnology company is scheduled to participate in the Cantor Virtual Global Healthcare Conference on September 17, 2020. The company is dedicated to the development of innovative medicines for the treatment of rare disorders.

Marinus Pharmaceutical has disclosed that it has received the five-year development contract with BARDA. The contract has been awarded to the company to support the development of IV ganaxolone for the treatment of refractory status epilepticus (RSE). There are many serious causes of RSE.

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) shares were trading up 51.66% at $3.20 at the time of writing on Tuesday. Marinus Pharmaceuticals, Inc. (MRNS) share price went from a low point around $1.01 to briefly over $3.50 in the past 52 weeks, though shares have since pulled back to $3.20. Marinus Pharmaceuticals, Inc. (MRNS) market cap has remained high, hitting $381.28 million at the time of writing.

In the Phase III trial, patients who have received the ganaxolone have shown a 32.2% median reduction in 28-day major motor frequency as compared to the 4% for placebo.

Chief Medical Officer Joe Hulihan of MRNS said that after receiving the positive result from the trial encouraged the company to accelerate the clinical studies in tuberous sclerosis complex and possibly other rare pediatric epilepsies as well.

September 16, 2020
Is Versace The Best Assets Of Capri Holdings Limited (NYSE: CPRI)?

Capri Holdings Limited (NYSE: CPRI), a multi-national holding fashion company revealed that its retail trends have improved in Q1 and Q2 through August. The company has participated in Goldman Sachs 27th Annual Global Retailing Conference. Capri Holdings Limited has also discussed its future revenue growth of $7B with FY21 estimates of $3.6B. Earlier, the Chairman and CEO of Capri talked about the strength of the company and labeled Versace as one of the best assets of Capri Holdings.

The fashion company is planning to grow Versace to $2 billion in sales by increasing its global footprint to 300 stores. Versace is considering the latest trends in the market to gain a competitive edge. CEO John said that the ongoing pandemic is not going to change the current business of the company.

He also disclosed the company’s plan to renovate all of the stores around the globe. Capri Holdings’ CEO said that the fashion company’s main focus is its accessories business where this company is very under-presented as compared to its other luxury peers.

London-based company has earlier named Hannah Colman as its chief executive officer Jimmy Choo, reporting to John D. Idol, Chairman, and CEO of Capri Holdings. Hannah Colman has keen knowledge and joined the company with her instinctive vision for the brand. Ms. Hannah has a deep understanding of the Jimmy Choo brand. She has joined the brand 24 years ago as the store manager in the first boutique in London.

Shares of Capri Holdings Limited traded down 0.70% as it lost -0.15 during the trading of Tuesday. It has an opening price of $21.60 and has a closing price of $21.15. In the past 52-weeks of trading, this company stock has fluctuated between the low range of $5.42 and a high range of $39.90. It has moved up 290.22% from its 52-weeks low and traded down -46.99% from its 52-weeks high. This company’s market capitalization has remained high, hitting $3.11 billion at the time of writing.

Idol revealed that Capri is planning to open roughly 300 Versace stores in the next few years around the globe, renovating its stores and increase the growth of its footwear and accessories business to about 60 percent of overall revenues. Furthermore, Idol disclosed that when the luxury brand has decided to bought Versace it has closed $150 million worth of business. The new Versace Barocco V collection is starting to grip the demands in the market. The company’s CEO labeled it a cornerstone for the development of the company.

September 16, 2020
Top 20 Oil And Gas Midstream Industry Stocks You Should Be Holding Right Now

One thing which is constant is change. Every sector is undergoing changes with the emergence of new trends and new advancements. The oil and gas industry is undergoing a significant shift because of the trends which are evolving and necessary to adopt for the growth of this sector. The oil and gas midstream industry gained the reputation of being one of the largest and most important industries in the world.

The midstream stage of oil and gas production follows a few important steps for bringing the product to market and brings a range of logistical, safety, and regulatory challenges. There are a few trends that will affect the industry in 2020. Even though 2020 is still underway, the trend predictions process is still continued. It is important for this industry to keep an eye on the new emerging trends.

Let see the top 20 leading companies which are adopting new trends and technologies to compete in the market:

Energy Transfer LP (NYSE: ET)

Energy Transfer LP (NYSE: ET) shares were trading down -1.35% at $5.84 at the time of writing on Tuesday. Energy Transfer LP (NYSE: ET) share price went from a low point around $3.75 to briefly over $14.03 in the past 52 weeks, though shares have since pulled back to $5.84. ET market cap has remained high, hitting $16.01B at the time of writing, giving it a price-to-sales ratio of more than 0.

Energy Transfer LP is planning to complete an expansion of its Dakota Access Pipeline by the third quarter of next year. Previously, it has disclosed the completion of its Lone Star Express Pipeline expansion project, which was a major part of Energy Transfer’s 2020 capital program. If we look at the recent analyst rating ET, RBC Capital Mkts reiterated coverage on ET shares with an Outperform rating.

Kinder Morgan Inc. (NYSE: KMI)

Kinder Morgan Inc. (NYSE: KMI) stock drop by -1.15% to $12.91. The most recent rating by Goldman, on July 07, 2020, is at a Sell. Kinder Morgan Inc. (KMI) Kinder Morgan resumes construction of the Texas natgas pipeline as suspicious package probed. Authorities have earlier investigated the suspicious packaged found at the construction site. Kinder Morgan Inc. has a market capitalization of $29.43 billion.

The Williams Companies Inc. (NYSE: WMB)

The Williams Companies Inc. (NYSE: WMB) Shares headed rising, higher as much as 0.10%. The most recent rating by Morgan Stanley, on July 15, 2020, is at an Overweight. The Williams Companies Inc. (WMB) has earlier participated in virtual meetings with investors, including a fireside chat Q&A session, at the Barclays CEO Energy-Power Conference on Wednesday, September 9. It has a total market capitalization of $25.26 billion.

Targa Resources Corp. (NYSE: TRGP)

Targa Resources Corp. (NYSE: TRGP) fall -1.31% after losing more than -$0.2 on Tuesday. Previously, Targa Resources Corp. (TRGP) disclosed its monthly distribution on the Partnership’s 9.00% Series a Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Units for September 2020. TRGP said that the board of directors of its general partner has announced a monthly cash distribution of $0.1875 per Series A Preferred Unit, or $2.25 per Series A Preferred Unit on an annualized basis, for September 2020.

Cheniere Energy Inc. (AMEX: LNG)

Cheniere Energy Inc. (AMEX: LNG) last closed at $48.27, in a 52-week range of $27.06 to $67.49. Cheniere Energy, Inc. has announced the Upsizing and Pricing of Inaugural Notes Offering. Cheniere Energy Inc. (LNG) has revealed its intention to offer, subject to market and other conditions, $1.0 billion aggregate principal amount of Senior Secured Notes due 2028. Analysts have a consensus price target of $66.84.

Enterprise Products Partners L.P. (NYSE: EPD)

Enterprise Products Partners L.P. (NYSE: EPD) fall -2.04% after losing more than -$0.35 on Tuesday. Enterprise Products Partners L.P. (EPD) has earlier participated in a Fireside Chat and host virtual investor meetings at the Barclays CEO Energy-Power Virtual Conference Wednesday, September 9, 2020. Enterprise Products Partners L.P. has a 52-weeks low range of $10.27 and a high range of $29.56. It has a market capitalization of $36.81 billion.

Plains All American Pipeline L.P. (PAA)

Plains All American Pipeline L.P. (PAA) stock drop by -0.44% to $6.86. The most recent rating by BofA Securities, on July 21, 2020, is at a Buy. Plains All American Pipeline L.P. (PAA) and Plains GP Holdings (PAGP) earlier received notice from an affiliate of Kayne Anderson Capital Advisors, L.P.that Robert V. Sinnott will be retiring from service. He will be replaced by Kevin McCarthy, Vice Chairman of Kayne Anderson. Mr. Sinnott has worked as a director of GP Holdings and its predecessors and affiliates for over 25 years.

ONEOK Inc. (NYSE: OKE)

ONEOK Inc. (NYSE: OKE) shares headed falling, lower as much as -3.70%. The most recent rating by Seaport Global Securities, on August 28, 2020, is at a Buy. Previously, ONEOK Inc. (OKE) has participated in Barclays CEO Energy-Power Virtual Conference Sept. 8-9, 2020. ONEOK Inc. has a 52-weeks low range of $12.16 and a high range of $78.48. It has a market capitalization of $11.54 billion.

DCP Midstream LP (NYSE: DCP)

DCP Midstream LP (NYSE: DCP) Shares headed falling, lower as much as -1.94%. The most recent rating by UBS, on July 13, 2020, is at a Neutral. DCP Midstream LP (DCP) has previously revealed that it has joined the World Economic Forum’s global lighthouse network. The Global Lighthouse Network is a platform to develop, replicate, and scale up innovations. It is best known for creating opportunities for cross-company learning and collaboration, and for setting new benchmarks for the global manufacturing community.

Equitrans Midstream Corporation (NYSE: ETRN)

Equitrans Midstream Corporation (NYSE: ETRN) last closed at $9.19, in a 52-week range of $3.75 to $15.24. Analysts have a consensus price target of $12.55. Equitrans Midstream Corporation (ETRN) has issued a statement regarding a contract dispute and the related attempt by EQT Corporation (EQT) and its financial advisor to market ETRN’s Hammerhead pipeline. Its market capitalization has remained high, hitting $3.90 billion at the time of writing.

Western Midstream Partners LP (NYSE: WES)

Western Midstream Partners LP (NYSE: WES) stock drop by -2.92% to $7.66. The most recent rating by Tudor Pickering, on August 21, 2020, is at a Buy. Western Midstream Partners LP (WES) revealed the exchange of its 98% interest in the $260 million 6.50% fixed-rate note receivable due 2038 from Occidental Petroleum Corporation for 27.855 million WES common units owned by Occidental.

Plains GP Holdings L.P. (NYSE: PAGP)

Plains GP Holdings L.P. (NYSE: PAGP) Shares headed falling, lower as much as -0.14%. The most recent rating by BofA Securities, on July 21, 2020, is at a Buy. Plains GP Holdings L.P. (PAGP) along with Plains All American Pipeline, L.P. has received notice of management changes. Robert V. Sinnott will be retiring from service as Kayne Anderson’s designated representative on the Board of Directors of PAA GP Holdings LLC.

Enbridge Inc. (ENB)

Enbridge Inc. (ENB) stock soar by 0.13% to $30.94. The most recent rating by Citigroup, on August 13, 2020, is at a Buy. Enbridge Inc. (ENB) revealed on Wednesday it will restart the East segment of its Line 5 pipeline in the Straits of Mackinac after receiving official permission from the U.S. federal pipeline regulator. It has a market cap of $62.42 billion at the tie of writing.

Antero Midstream Corporation (NYSE: AM)

Antero Midstream Corporation (NYSE: AM) last closed at $5.22, in a 52-week range of $1.69 to $8.45. Antero Midstream Corporation (AM) has traded up 208.88% from its 52-weeks low and traded down -38.22% from its 52-weeks low. Looking at its liquidity, it has a current ratio of 1.00. Analysts have a consensus price target of $6.33. Antero Midstream Corporation (AM) market cap has remained high, hitting $2.48 billion.

Golar LNG Limited (NASDAQ: GLNG)

Golar LNG Limited (NASDAQ: GLNG) stock soar by 2.97% to $12.15. The most recent rating by Cowen, on May 29, 2020, is at an Outperform. Golar LNG Limited (GLNG) share price went from a low point around $4.54 to briefly over $15.86 in the past 52 weeks, though shares have since pulled back to $12.15. Golar LNG Limited market cap has remained high, hitting $1.12 billion at the time of writing.

EnLink Midstream LLC (NYSE: ENLC)

EnLink Midstream LLC (NYSE: ENLC) fall -2.72% after losing more than -$0.07 on Tuesday. In the at 52-weeks of trading, EnLink Midstream LLC (ENLC) stock has fluctuated between the low of $0.88 and a high of $9.37. It has moved up 184.09% from its 52-weeks low and moved down -73.32% from its 52-weeks high. Its market capitalization has remained high, hitting $1.22 billion at the time of writing.

Frontline Ltd. (NYSE: FRO)

Frontline Ltd. (NYSE: FRO) Shares headed falling, lower as much as -4.76%. The most recent rating by DNB Markets, on May 28, 2020, is at a Buy. Frontline Ltd. (FRO) share price went from a low point around $6.09 to briefly over $13.33 in the past 52 weeks, though shares have since pulled back to $7.41. Frontline Ltd.’s market cap has remained high, hitting $1.42 billion at the time of writing.

Euronav NV (NYSE: EURN)

Euronav NV (EURN) last closed at $9.55, in a 52-week range of $7.85 to $13.21. Analysts have a consensus price target of $14.11. in the at 52-weeks of trading, Euronav NV (EURN) stock has fluctuated between the low of $7.85 and a high of $13.21. It has moved up 21.66% from its 52-weeks low and moved down -27.71% from its 52-weeks high. Its market capitalization has remained high, hitting $1.96 billion at the time of writing.

DHT Holdings Inc. (NYSE: DHT)

DHT Holdings Inc. (NYSE: DHT) fall -5.08% after losing more than -$0.3 on Tuesday. DHT Holdings Inc. (DHT) share price went from a low point around $4.77 to briefly over $8.83 in the past 52 weeks, though shares have since pulled back to $5.60. DHT Holdings Inc.’s market cap has remained high, hitting $888.66 million at the time of writing.

MPLX LP (NYSE: MPLX)

MPLX LP (NYSE: MPLX) last closed at $17.49, in a 52-week range of $6.87 to $30.53. Analysts have a consensus price target of $23.60. MPLX LP (MPLX) has moved up 154.59% from its 52-weeks low and moved down -42.71% from its 52-weeks high. Its market capitalization has remained high, hitting $18.46 billion at the time of writing.

September 16, 2020
15 Trending Stocks In Banking Industry To Invest In

Digitalization has changed the way how people interact with each other and how they pursue their business activities. Similarly, the advancements and emergence of new banking technologies are continuing to influence the future of financial services around the globe. Digitalization and automation will continue to bring structural adjustments in the size of the bank industry workforce.

Banks diversified industry is known for its diversified services to its customers according to their needs. Financial companies provide various financial services to various institutes, governments, consumers, and various corporations. Diversified financial services company provides banking, investment, mortgage, and various products and services to businesses, institutions, and individuals, around the world.

Here are the top best-performing companies in the diversified banking sector which are following new market trends to provide the best services to customers:

Citigroup Inc. (NYSE:C)

Citigroup Inc. (NYSE:C) shares were trading down -6.94% at $44.81 at the time of writing on Tuesday. Citigroup Inc. (NYSE:C) share price went from a low point around $32.00 to briefly over $83.11 in the past 52 weeks, though shares have since pulled back to $44.81. C market cap has remained high, hitting $93.20B at the time of writing, giving it a price-to-sales ratio of more than 1.

Federal regulators are gearing up to reprimand Citigroup Inc for failing to improve its risk-management systems. Citigroup Inc. (NYSE:C) has earlier disclosed its long-term partnership with Wayfair to provide a new private label Wayfair credit card and a co-brand Wayfair Mastercard. The decision of partnership came after Citigroup saw an increase in demand for online shopping. If we look at the recent analyst rating C, Odeon downgraded coverage on C shares with a Sell rating and a $69.21 price target, which implies room for 24.4% upside momentum this year.

Bank of America Corporation (NYSE: BAC)

Bank of America Corporation (BAC) last closed at $25.28, in a 52-week range of $17.95 to $35.72. Bank of America has announced redemption of senior notes. The redemption price for each series of the Senior Notes will be equal to 100% of the principal amount of such series, plus accrued and unpaid interest. It also excludes, the redemption date of October 1, 2020. Analysts have a consensus price target of $28.61.

JPMorgan Chase & Co. (NYSE: JPM)

JPMorgan Chase & Co. (NYSE: JPM) Shares headed falling, lower as much as -3.11%. The most recent rating by Deutsche Bank, on September 03, 2020, is at a Buy. JPMorgan Chase & Co. (JPM) and BlackRock Inc both entered into a partnership agreement with AI technology startup Saphyre to automate the opening of custody accounts. It was also the winning bidder on $900 million of New York Metropolitan Transportation Authority debt to finance subway, bus, and commuter-rail capital projects as the transit agency.

Credit Suisse Group AG (NYSE: CS)

Credit Suisse Group AG (NYSE: CS) stock drop by -2.41% to $10.92. The most recent rating by Exane BNP Paribas, on September 03, 2020, is at an Outperform. Credit Suisse Group AG (CS) and UBS Group are planning to create one of Europe’s largest banks. Credit Suisse has announced that it will launch a digital banking app in October challenging fintech like Revolut in the Swiss bank’s home market by offering free foreign transactions and fully digital wealth management.

The Toronto-Dominion Bank (NYSE: TD)

The Toronto-Dominion Bank (NYSE: TD) stock drop by -0.27% to $47.95 after TD has introduced its annual TD Thanks You campaign. The campaign aimed at thanking and rewarding those who are making an impact in their communities during this ongoing pandemic. The most recent rating by Barclays, on August 19, 2020, is at an Equal-weight.

UBS Group AG (NYSE: UBS)

UBS Group AG (NYSE: UBS) stock drop by -1.84% to $12.29 after UBS YES INVESTORS: Dimond Kaplan & Rothstein, P.A. has lodged another FINRA Arbitration claim to recover yield enhancement strategy options losses. The FINRA claim stated that UBS misreport the risks of its options program and failed to use proper risk controls. The most recent rating by Berenberg, on May 04, 2020, is at a Hold.

Mitsubishi UFJ Financial Group Inc. (NYSE: MUFG)

Mitsubishi UFJ Financial Group Inc. (NYSE: MUFG) fall -0.24% after losing more than -$0.01 on Tuesday. Alphabet, Google’s parent company, Drager, and Peloton are the finalists for the AFP 2020 Pinnacle Award. The Pinnacle Award was sponsored by Mitsubishi UFJ Financial Group MUFG. The Pinnacle Award was established in 1997 to recognize excellence in treasury and finance.

Barclays PLC (NYSE: BCS)

Barclays PLC (NYSE: BCS) Shares headed falling, lower as much as -1.32%. The most recent rating by Investec, on July 10, 2020, is at a Buy. Barclays PLC has earlier disclosed that it will use its issuer call option and redeem, in full, its iPath MSCI India Index ETNs due December 18, 2036, on September 25, 2020. Previously, Apple Inc revealed on Tuesday that it has ended its long-time card partnership with Barclays Plc. The decision was taken to move designed to focus attention on its own Apple Card product-financing plans.

HSBC Holdings plc (NYSE: HSBC)

HSBC Holdings plc (NYSE: HSBC) last closed at $20.71, in a 52-week range of $20.54 to $39.69. Analysts have a consensus price target of $22.56. HSBC Holdings plc (HSBC) has earlier revealed that it has launched the Thought Leadership Webinar Series during climate week NYC. Climate Week NYC is one of the largest international summits focused on climate change. It will be hosted in association with the United Nations and the City of New York.

Wells Fargo & Company (NYS: WFC)

Wells Fargo & Company (NYSE: WFC) stock soar by 0.28% to $24.88. The most recent rating by Wolfe Research, on September 14, 2020, is at an Outperform. Wells Fargo & Company (WFC) share price went from a low point around $22.00 to briefly over $54.75 in the past 52 weeks, though shares have since pulled back to $24.88. Wells Fargo & Company (WFC) market cap has remained high, hitting $101.16 billion at the time of writing.

Banco Santander S.A. (NYSE: SAN)

Banco Santander S.A. (NYSE: SAN) fall -1.40% after losing more than -$0.03 on Tuesday. Banco Santander S.A. (SAN) shares fluctuated between the 52-weeks low range of $1.90 and a high range of $4.42. It has moved up 11.58% from its 52-weeks low and moved down -52.04% from its 52-weeks high. Banco Santander S.A.’s market capitalization has remained high, hitting $36.23 billion at the time of writing.

Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA)

Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA) last closed at $2.82, in a 52-week range of $2.64 to $5.80. Analysts have a consensus price target of $2.94. Banco Bilbao Vizcaya Argentaria S.A. (BBVA) share price went from a low point around $2.10 to briefly over $6.31 in the past 52 weeks, though shares have since pulled back to $3.14. Banco Bilbao Vizcaya Argentaria S.A. market cap has remained high, hitting $1.16 billion at the time of writing.

ING Groep N.V. (NYSE: ING)

ING Groep N.V. (NYSE: ING) fall -0.95% after losing more than -$0.08 on Tuesday. ING Groep N.V. (ING) shares fluctuated between the 52-weeks low range of $4.52 and a high range of $12.44. It has moved up 84.07% from its 52-weeks low and moved down -33.12% from its 52-weeks high. ING Groep N.V.’s market capitalization has remained high, hitting $32.89 billion at the time of writing.

NatWest Group plc (NYSE: NWG)

NatWest Group plc (NYSE: NWG) Shares headed falling, lower as much as -1.15%. NatWest Group plc (NWG) share price went from a low point around $2.40 to briefly over $6.76 in the past 52 weeks, though shares have since pulled back to $2.57. NatWest Group plc. market cap has remained high, hitting $16.18 billion at the time of writing.

Sumitomo Mitsui Financial Group Inc. (NYSE: SMFG)

Sumitomo Mitsui Financial Group Inc. (NYSE: SMFG) last closed at $5.91, in a 52-week range of $4.49 to $7.56. Analysts have a consensus price target of $9.26. Sumitomo Mitsui Financial Group Inc. (SMFG) fluctuated between the 52-weeks low range of $4.49 and a high range of $7.56. It has moved up 31.36% from its 52-weeks low and moved down -21.83% from its 52-weeks high. Sumitomo Mitsui Financial Group Inc.’s market capitalization has remained high, hitting $40.47 billion at the time of writing.

September 16, 2020
AT&T Stock Announces 5G Roaming Services For US Customers In Japan

AT&T Inc. (NYSE: T), an American multinational company has announced that it has signed an International Roaming Agreement with NTT DOCOMO, Inc., a mobile phone operator company in Japan. AT&T will be able to fulfill its promise of keeping its customer connected and providing them access to 5G through this agreement. AT&T customers in the US will be able to access 5G services when they use 5G roaming capable devices such as Motorola one 5G.

NTT DOCOMO Inc. has introduced its 5G services in Japan in March and became the first mobile operator in Japan to provide an inbound 5G roaming services to customers. Japanese-based company has disclosed Monday that it will allow foreign operators and their customers in Japan to avail DOCOMO 5G roaming services.

AT&T announced that its nationwide services will get better with the Motorola one 5G which is scheduled to arrive on 18 September 2020. This latest 5G smartphone includes an ultra-wide-angle selfie camera, a large CinemaVision full HD+ display and so much more. Customers will be able to get the device from any AT&T retail store or from its website at a very affordable price.

AT&T Inc shares were trading up 0.48% at $29.14 at the time of writing on Tuesday. AT&T Inc share price went from a low point around $26.08 to briefly over $39.70 in the past 52 weeks, though shares have since pulled back to $29.14. It has moved up 11.73% from its 52-weeks low and moved down -26.60% from its 52-weeks high. AT&T market cap has remained high, hitting $206.98 billion at the time of writing.

AT&T is considered to be the leader in global roaming. The company aimed to provide next-generation services to its customers without stopping its efforts for the development and innovation of new technology for its customers. This new deal with DOCOMO is a huge deal for AT&T and for its customers.

September 15, 2020
Top Biotech Stocks to Watch as Equities Rally

The markets are up this morning driven by a combination of COVID-19 vaccine excitement, and China-related news. On COVID-19 vaccine news, the announcement by AstraZeneca that it was restarting its late-stage COVID-19 vaccine trial is still exciting the market. Given that this is one of the most promising vaccine candidates in the market, investors are taking the latest development as a sign of good things to come. The excitement stems from the fact that a COVID-19 vaccine can lead to a revamp of the economy, due to a resumption of consumer spending.

The U.S economy thrives on consumer spending and a return to pre-COVID-19 levels of spending would see the stock market’s rally again as investors throw money more confidently at the stock markets. On China, the country has reported positive data on industrial production and retail sales. The country has stated that industrial production increased by 5.6%, while retails grew by 0.5%. Given how important China is to the global economy, the growth data points to both economic resilience, and a potential bounce back in the world economy once a vaccine is found.

As optimism rises in the markets, biotech stocks are leading the way in early morning gains. Some of the top stock performers ahead of markets are as below:

Novus Therapeutics Inc [NASDAQ: NVUS]

This stock is gaining quite strongly pre-market and is up by over 150%. This follows the company’s announcement that it was buying privately-held Analixis Therapeutics Inc. Through the acquisition, the company will have access to compound AT-1501, a next-gen anti-CD40L antibody.

Once developed, it will be used for organ and cellular transplants, when treating autoimmune and neurodegenerative diseases. The company will also inherit Anelixis senior management that has lots of experience in drug development and commercialization. Commenting on the deal, board chairman Keith A. Katkin stated that the acquisition would deliver value to Novus shareholders.

Marinus Pharmaceuticals Inc [NASDAQ: MRNS]

Marinus Pharmaceuticals Inc is another top performer this morning and is up by over 60%. This follows the company’s announcement that Ganaxolene has met its primary endpoint in the company’s phase 3 trial for CDKL5 deficiency disorder The Company has also announced that the treatment was well-tolerated and that it had a discontinuation rate of under 5%.

ARCA Biopharma Inc [NASDAQ: ABIO]

ARCA Biopharma is another top performer this morning and is up by over 20%. This is largely price action-driven, and comes a month after the company announced that it had completed its FDA pre-IND consultation for its severe COVID-19 treatment. The company expects to submit its IND this month ahead of its phase 2b clinical trials.

September 15, 2020
Nvidia (NASDAQ: NVDA) Stock Keep Rising Amid ARM Deal

NVIDIA Corporation (NASDAQ: NVDA) has announced that it has decided to acquire Arm Ltd. from SoftBank Inc. for about $40 billion in stock and cash deal. This deal is considered to be the first-ever deal of this kind in the semi-conductor industry but Nvidia Inc has received a strong backlash from its rival. Nvidia deal with SoftBank would put Arm Ltd under the control of a US-based firm in the middle of a battle between the US and China.

Arm Ltd. has a strong reach as a supplier of designs and intellectual property to most of the global semiconductor industry. It is considered to be the major supplier of its technology to companies such as Intel Corp, Samsung Electronics Co Ltd, and Qualcomm Inc who increasingly compete with Nvidia. Nvidia Corporation is anticipated to close the deal in 18 months after receiving regulatory approval but there are speculations that the deal will be delayed.

ARK Invest Analyst James Wang said that this deal required approval from four countries the UK, the US, China, and Japan so there are 50/50 chances that the deal will be delayed. The analyst said that this is a complicated deal and it is too early to say that this will be completed or not. Mark Lipacis maintained a Buy rating for Nivida as he raised the price target from $570 to $680.

Geoff Blaber, vice president of research for the Americas with CCS Insights revealed that this deal will receive a lot of obstacles and will encounter huge criticism from the customers of Arm Ltd. Nvidia Chief Executive Jensen Huang and Arm Chief Executive Simon Segars made a very interesting point that because the company is based in the UK, it is free from US trade barriers and regulations. Nvidia will maintain the UK headquarter of Arm Ltd.

Shares of Nvidia Corporation (NASDAQ: NVDA) soared 5.82% as it gained +28.31 during the trading session of Monday. NVDA share price went from a low point around $169.32 to briefly over $589.07 in the past 52 weeks, though shares have since pulled back to $514.89. Nvidia Corporation’s market cap has remained high, hitting $321.53 billion at the time of writing. Looking at its liquidity, it has a current ratio of 6.10.

Nvidia said that the Arm will continue to work as a neutral supplier after the deal and it will not interfere in any Arm’s Licensing efforts. But the deal has garnered a huge criticism. One of the Chinese chip executives said that it is hard to give services in China if Arm had an American Parent company. South-Korean chip officials said that after this deal Arm could increase the licensing fees for the competitors.

The combination of Nvidia and Arm Ltd will reshape the semiconductor industry in the coming years. After this deal, Nvidia will be able to gain the ability to own the whole chip stack, across mobile phones, computers, and cloud-computing data centers.

September 15, 2020
Is Pfizer Inc. (NYSE: PFE) A Good Investment?

Shares of Pfizer Inc. (NYSE: PFE) traded up 2.61% after gaining +0.94 on Monday as it may be the first to disclose the late-stage study result from its trials with partner BioNTech SE. Pfizer Inc. is currently conducting one of the most advanced trials of a vaccine for novel coronavirus.

It has commenced the Phase 2/3 study of BNT162b2, a most advanced coronavirus vaccine candidate in July. Almost 30,000 participants were enrolled in the trial who received two doses of the vaccine candidate.

Pfizer CEO Albert Bourla revealed that the FDA committee will gather to discuss vaccines on Oct 22. CEO said that the company has a deep understanding of this matter and it will be able to present the efficacy data of Phase 3 before the end of October.

He said that the company is not bound to any deadline. Albert Bourla said that FDA is searching for companies to review their vaccines that are at least 50% effective. Pfizer is hoping for a better result as its Phase 3 trial with 30,000 people is almost completed.

Goldman Sachs labeled this a vaccine trade as the investors were attracting towards stocks that were developing a vaccine or any treatment of diseases and they dumped the stock soon after hearing the good news. The same thing happened with Gilead Sciences as its shares tumbled down after it has got the regulatory approval for its antiviral medicine of COVID-19.

Pfizer Inc. (NYSE: PFE) share price went from a low point around $27.88 to briefly over $40.97 in the past 52 weeks, though shares have since pulled back to $37.01. Pfizer Inc. has moved up 32.75% from its 52-weeks low and moved down -9.67% from its 52-weeks high. Pfizer Inc.’s market cap has remained high, hitting $203.27 billion at the time of writing. If we look at its liquidity, it has a current ratio of 1.40.

Pfizer Inc and BioNTech SE have recently disclosed that they striving to secure the approval of the US FDA to expand the late-stage clinical trial of their COVID-19 vaccine. Earlier, Pfizer has enrolled the 30,000 participants in the trial but now it is looking for the trial which will enroll 44,000 volunteers as the company is trying to add the young population in the late-stage study.

Previously, the US Government has revealed that it would pay $1.95 billion to companies for the supply of 100 million doses of vaccine if it received regulatory approval. CEO Pfizer also disclosed that the company has invested $1.5 billion for the development of a vaccine and if the trial is not successful it is painful for the company.

September 15, 2020
Top 10 Machinery Manufacture Stocks to Watch

Industrial machines played a very important role in reducing the efforts of humans and also increases the efficiency and speed of work. The machinery industry is closely related to economic conditions. Industrial machinery manufacturers are engaged in the usage of the Industrial Internet of things for faster production and delivery of industrial machinery to customers. Using technology in the industrial machinery sector enhanced production efficiency & lower manufacturing costs.

2020 is the year of challenges and opportunities for the Specialty Industrial Machinery industry. It is anticipated that the increasing population and high disposable income among middle-class people will increase the growth of the industrial machinery market. Rapid technological changes and industrialization has played a very important role in the growth of industrial market size.

Here are some leading companies in the Specialty Industrial Machinery Industry that are changing with evolving technologies:

General Electric Company (NYSE: GE)

General Electric Company (NYSE: GE) shares were trading up 3.36% at $6.15 at the time of writing on Monday. General Electric Company (NYSE: GE) share price went from a low point around $5.48 to briefly over $13.26 in the past 52 weeks, though shares have since pulled back to $6.15. GE market cap has remained high, hitting $54.29B at the time of writing, giving it a price-to-sales ratio of more than 0.

General Electric Company has recently secured an Onshore wind turbine deal in Austria. As per the deal, the General Electic company will deliver 30 of its advanced Cypress turbines which are capable of operating at 5.5 MW. Both companies will work on installing the turbines at PÜSPÖK Group’s two wind farm facilities based in the Burgenland region. The installation of the turbines is anticipated to start in the first quarter of 2021. If we look at the recent analyst rating GE, Argus reiterated coverage on GE shares with a Buy rating and a $7.75 price target, which implies room for 1.6% upside momentum this year.

Welbilt Inc. (NYSE: WBT)

Welbilt Inc. (NYSE: WBT) last closed at $7.24, in a 52-week range of $3.17 to $19.81. Analysts have a consensus price target of $8.88. Welbilt Inc. (WBT) is scheduled to participate in the upcoming two conferences including Morgan Stanley’s Virtual 8th Annual Laguna Conference on September 15th and C.L. King’s 2020 Virtual Best Ideas Conference on September 16th. Welbilt Inc.’s market capitalization has remained high, hitting $1.03 billion at the time of writing.

Otis Worldwide Corporation (NYSE: OTIS)

Otis Worldwide Corporation (NYSE: OTIS) fall -0.25% after losing more than -$0.15 on Monday. Otis Worldwide Corporation (NYSE: OTIS) has previously revealed that it has commissioned a study into elevator airflow, how it affects the risk of transmission of the COVID-19 virus among passengers, and how to mitigate those risks through science-based safety protocols. Otis Worldwide Corporation moved up 57.87% from its 52-weeks low and moved down -9.04% from its 52-weeks high.

3M Company (MMM)

3M Company (MMM) last closed at $168.46, in a 52-week range of $114.04 to $182.54. Analysts have a consensus price target of $163.00. 3M Company (MMM) is scheduled to participate in the upcoming Morgan Stanley Virtual 8^th Annual Laguna Conference which is scheduled to take place on September 17, 2020. 3M Company has a total market capitalization of $95.27 billion at the time of writing.

Ingersoll Rand Inc. (NYSE: IR)

Ingersoll Rand Inc. (NYSE: IR) shares headed rising, higher as much as 0.94%. The most recent rating by Goldman, on June 15, 2020, is at a Neutral. Ingersoll Rand Inc. (NYSE: IR) is scheduled to participate in the 2020 Morgan Stanley Laguna Conference on Tuesday, September 15. Previously, it has disclosed that it has acquired Montelimar, France-based Albin Pump SAS. The transaction value wasn’t disclosed yet and was financed with available cash.

Xylem Inc. (NYSE: XYL)

Xylem Inc. (NYSE: XYL) fall -0.40% after losing more than -$0.34 on Monday. Previously, Xylem Inc. (XYL) disclosed that its President and CEO, Patrick Decker, and Vice President of Investor Relations, Matt Latino, will participate in a virtual fireside chat hosted by RBC analyst Deane Dray on Tuesday, September 15, 2020,

Mueller Water Products Inc. (NYSE: MWA)

Mueller Water Products Inc. (NYSE: MWA) last closed at $10.86, in a 52-week range of $6.64 to $12.71. Mueller Water Products to Participate in the 2020 RBC Capital Markets Global Industrials Virtual Conference. Analysts have a consensus price target of $11.70.

Howmet Aerospace Inc. (NYSE: HWM)

Howmet Aerospace Inc. (NYSE: HWM) stock soar by 3.31% to $18.39. The most recent rating by Barclays, on September 10, 2020, is at an Overweight. Howmet Aerospace Inc. (HWM) share price went from a low point around $8.72 to briefly over $26.27 in the past 52 weeks, though shares have since pulled back to $18.39. Howmet Aerospace Inc. market cap has remained high, hitting $7.65 billion at the time of writing.

Emerson Electric Co. (NYSE: EMR)

Emerson Electric Co. (NYSE: EMR) Shares headed rising, higher as much as 0.40%. The most recent rating by Berenberg, on August 20, 2020, is at a Buy. In the 52-weeks of trading, Emerson Electric Co. (EMR) stock fluctuated between the low range of $37.75 and a high range of $78.38. It has moved up 80.64% from its 52-weeks low and moved down 13.00% from its 52-weeks high. Emerson Electric Co.’s market capitalization has remained high, hitting $40.50 billion at the time of writing.

Honeywell International Inc. (NYSE: HON)

Honeywell International Inc. (NYSE: HON) stock soar by 1.21% to $168.47. The most recent rating by RBC Capital Mkts, on August 11, 2020, is at a Sector perform. Honeywell International Inc. (HON) share price went from a low point of around $101.08 to briefly over $184.06 in the past 52 weeks, though shares have since pulled back to $168.47. Honeywell International Inc.’s market cap has remained high, hitting $116.68 billion at the time of writing.

September 15, 2020
20 Trending Stocks In Biotechnology Industry That Need Your Attention

Biotechnology is considered to be the backbone of many industrial sectors and it makes a significant contribution to the well being of society. Every single day we saw changes in every sector as we experience advancements of knowledge and the new technological breakthroughs. One of the industries that constantly change is the biotechnology industry.

2020 is the year of continuous development and improvement in drug research. This industry is the leading rapidly growing sector of the economy. There are various trends in the biotechnology industry that the world should expect in the coming years such as the production of personalized medicines thanks to the advancement in genetics and continuous development and improvement in drug research.

Let’s take a quick look at the 20 leading companies which are following new trends in the biotechnology sector:

Vaxart Inc. (NASDAQ: VXRT)

Vaxart Inc. (NASDAQ: VXRT) shares were trading up 46.79% at $7.78 at the time of writing on Monday. Vaxart Inc. (NASDAQ: VXRT) share price went from a low point around $0.25 to briefly over $17.49 in the past 52 weeks, though shares have since pulled back to $7.78. VXRT market cap has remained high, hitting $766.25M at the time of writing, giving it a price-to-sales ratio of more than 90.

Vaxart Inc. has revealed that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral COVID-19 vaccine candidate. Vaxart Inc. also gave an update on its COVID-19 program.

Cassava Sciences Inc. (NASDAQ: SAVA)

Cassava Sciences Inc. (NASDAQ: SAVA) last closed at $7.75, in a 52-week range of $1.05 to $10.95. Cassava Sciences has announced the final results of a Phase 2bclinical study of Sumifilam in patients with Alzheimer’s Disease. Sumifilam is the first of a new class of drug compounds that bind to a protein called Filamin A. Cassava Sciences Inc. (SAVA) has earlier held a conference call on September 14. Cassava Sciences Inc.’s market cap has remained high, hitting $182.51 million at the time of writing.

Immunomedics Inc. (IMMU)

Immunomedics Inc. (IMMU) stock soar by 97.99% to $83.65. The most recent rating by Barclays, on May 05, 2020, is at an Overweight. Gilead Sciences Inc. (NASDAQ: GILD) has earlier announced that it has decided to buy biotech company Immunomedics Inc for $21 billion. This decision will strengthen its cancer portfolio by gaining access to a promising drug. Immunomedics Inc. (IMMU) has a total market capitalization of $19.19 billion.

Sorrento Therapeutics Inc. (NASDAQ: SRNE)

Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares headed rising, higher as much as 17.88%. The most recent rating by H.C. Wainwright, on July 31, 2020, is at a Buy. Sorrento Therapeutics Inc. (NASDAQ: SRNE) has earlier disclosed that it has signed an exclusive license agreement with Mayo Clinic for an antibody-drug-nanoparticle albumin-bound (nab) immune complexes (ADNICs) platform targeting many types of human diseases including various solid and liquid tumors. Sorrento Therapeutics Inc. has a market cap of $1.86 billion.

Novan Inc. (NASDAQ: NOVN)

Novan Inc. (NASDAQ: NOVN) rose 13.00% after gaining more than $0.06 on Monday. Novan Provides Pipeline and Priority Development Programs Update. Novan Inc. (NOVN) gave a pipeline and priority development programs update. Novan Inc.’s share price went from a low point around $0.22 to briefly over $3.72 in the past 52 weeks, though shares have since pulled back to $0.53. Novan Inc.’s market cap has remained high, hitting $82.02 million at the time of writing.

Inovio Pharmaceuticals Inc. (NASDAQ: INO)

Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock soar by 12.30% to $11.32. The most recent rating by ROTH Capital, on July 01, 2020, is at a Sell. Inovio Pharmaceuticals Inc. (INO) has earlier signed a manufacturing agreement with Thermo Fisher Scientific. Thermo Fisher Scientific has signed a letter of intent to manufacture INOVIO’s DNA COVID-19 vaccine candidate INO-4800.

Evofem Biosciences Inc. (NASDAQ: EVFM)

Evofem Biosciences Inc. (NASDAQ: EVFM) Shares headed rising, higher as much as 11.90% after Evofem Biosciences to present data at the 2020 STD prevention Virtual Conference from Phase 2b Trial of EVO100 for prevention of Chlamydia and Gonorrhea in Women. The most recent rating by Morgan Stanley, on August 20, 2020, is at an Equal-weight.

iBio Inc. (AMEX: IBIO)

iBio Inc. (AMEX: IBIO) rose 9.28% after gaining more than $0.18 on Monday. iBio Inc. (AMEX: IBIO) has earlier disclosed that it has selected IBIO-201, its LicKM-ubunit vaccine, as its leading candidate for the prevention of SARS-CoV-2 infection. iBio revealed earlier the preclinical immunization studies with IBIO-200 and IBIO-201, combined with select adjuvants from the Infectious Disease Research Institute, induced anti-SARS-CoV-2 antibodies. iBio Inc has a market capitalization of $379.31 million.

Clovis Oncology Inc. (CLVS)

Clovis Oncology Inc. (CLVS) last closed at $7.00, in a 52-week range of $2.93 to $17.37. CLVS has traded up 138.91% from its 52-weeks low and traded down -59.70% from its 52-weeks high. Analysts have a consensus price target of $9.00. Clovis Oncology Inc. (CLVS) has earlier announced Oral Plenary Session Presentation at the International Gynecologic Cancer Society (IGCS)digital annual global meeting.

Heat Biologics Inc. (NASDAQ: HTBX)

Heat Biologics Inc. (NASDAQ: HTBX) stock soar by 1.82% to $1.12. The most recent rating by ROTH Capital, on June 20, 2016, is at a Buy. Heat Biologics Inc. (HTBX) has earlier participated in a virtual panel, entitled, “New Approaches to COVID-19: Hidden Breakthroughs,” being held on Thursday, September 10. Heat Biologics has also issued a key patent on combination platform therapy. Heat Biologics Inc. has a total market capitalization of $170.96 million.

VBI Vaccines Inc. (NASDAQ: VBIV)

VBI Vaccines Inc. (NASDAQ: VBIV) shares headed rising, higher as much as 12.82% after VBI Vaccines to present additional biomarker data from VBI-1901 Phase 1/2a Study in Recurrent GBM in an E-Poster at ESMO Virtual Congress 2020. The most recent rating by Raymond James, on August 27, 2020, is at a Strong buy. Its market capitalization has remained high, hitting $813.82 million.

Dynavax Technologies Corporation (NASDAQ: DVAX)

Dynavax Technologies Corporation (NASDAQ: DVAX) rose 13.37% after gaining more than $0.67 on Monday. Valneva and Dynavax have announced a Commercial supply agreement for Inactivated, adjuvanted COVID-19 vaccine. This is a commercial partnership for the supply of Dynavax’s CpG 1018 adjuvant for use in Valneva’s SARS-CoV-2 vaccine candidate, VLA2001. Dynavax will supply CpG 1018 to produce up to 100 million doses of vaccine in 2021. Valneva has the opportunity to purchase up to an additional 90 million doses through 2025.

Zosano Pharma Corporation (NASDAQ: ZSAN)

Zosano Pharma Corporation (NASDAQ: ZSAN) last closed at $1.72, in a 52-week range of $0.41 to $2.45. Zosano Pharma Corporation (ZSAN) is scheduled to participate in a Cantor Virtual Global Healthcare Conference on Tuesday, September 15, 2020. At the conference, Zosano Pharma Corporation will present the company overview. Zosano Pharma Corporation has a total market capitalization of $138.86 million at the time of writing.

Moderna Inc. (NASDAQ: MRNA)

Moderna Inc. (NASDAQ: MRNA) stock soar by 7.30% to $63.67. The most recent rating by SVB Leerink, on September 08, 2020, is at an Underperform. Moderna Inc. (MRNA) has earlier named Michael Millette as Managing Director, Canada effective immediately. Michael Millette has joined Moderna Inc in August 2020 as Vice President. Moderna Inc has a total market cap of $24.37 billion at the time of writing.

9 Meters Biopharma Inc. (NASDAQ: NMTR)

9 Meters Biopharma Inc. (NASDAQ: NMTR) Shares headed rising, higher as much as 12.61%. 9 Meters Biopharma Inc. (NASDAQ: NMTR) is scheduled to participate in the upcoming two conferences in September including H.C. Wainwright: 22nd Annual Global Investment Conference and Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. These two conferences are scheduled to take place on September 15 and September 23, respectively.

Ampio Pharmaceuticals Inc. (AMEX: AMPE)

Ampio Pharmaceuticals Inc. (AMEX: AMPE) rose 10.80% after gaining more than $0.08 on Monday. Ampio Pharmaceuticals Inc. (AMPE) has revealed positive results in the early trial for intravenous Ampion treatment for COVID-19 patients on September 9, 2020. The Phase I trial was continued in the supervision of Michael Roshon, MD, Ph.D., Chief of Staff at Penrose-St. Francis Hospital in Colorado Springs, Colorado.

Novavax Inc. (NASDAQ: NVAX)

Novavax Inc. (NASDAQ: NVAX) last closed at $105.80, in a 52-week range of $3.54 to $189.40. Novavax Inc. (NVAX) is scheduled to participate in the upcoming three conferences including Cantor Virtual Global Healthcare Conference, Morgan Stanley Virtual 18th Annual Global Healthcare Conference, and Leerink CyberRx Series: Vaccine Forum on September 15, 16, and 23, respectively. It has earlier participated in Citi 15^th Annual BioPharma Virtual Conference, and H.C. Wainwright 22nd Annual Global Investment Conference on September 10, and 14, 2020, respectively.

Marinus Pharmaceuticals Inc. (NASDAQ: MRNS)

Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) stock soar by 5.50% to $2.11. The most recent rating by H.C. Wainwright, on July 01, 2020, is at a Buy. Marinus Pharmaceuticals Inc. (MRNS)has disclosed that it has entered into a five-year development contract with the Biomedical Advanced Research and Development Authority (BARDA) to support the development of IV ganaxolone for the treatment of refractory status epilepticus (RSE).

Onconova Therapeutics Inc. (NASDAQ: ONTX)

Onconova Therapeutics Inc. (NASDAQ: ONTX) Shares headed falling, lower as much as -3.28%. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy. Onconova Therapeutics Inc. (NASDAQ: ONTX) has earlier participated in two virtual events including Marcus Evans Healthcare Investment Webinar on September 10 and H.C. Wainwright 22nd Annual Global Investment Conference onSeptmerb 14. It is scheduled to participate in the 2nd Annual RAS-Targeted Drug Development Conference on September 16, 2020.

Trevena Inc. (NASDAQ: TRVN)

Trevena Inc. (NASDAQ: TRVN) last closed at $2.08, in a 52-week range of $0.46 to $3.68. In the past 52-weeks of trading, Trevena Inc. (TRVN) stock fluctuated between the low of $0.46 and a high of $3.68. It has moved up $352.17% from its 52-weeks low and moved down -43.48% from its 52-weeks high. Its market capitalization is $306.38 million at the time of writing.

September 15, 2020